The global PCR/RT market size is projected to reach USD 11.5 billion by 2026 at a CAGR of 6.7% from USD 7.5 billion in 2021 during the forecast period 2021-2028.
PCR or polymerase chain reaction is a widely used method for making multiple copies of a specific DNA sample. This is used in order to amplify the content of the desired segment of a DNA in a cell free medium. It was first invented in 1983 by Kary Mullis. The DNA polymerase enzyme used in the process is Taq polymerase as it is a thermostable polymerase.
With the surge in case of infectious disease and genetic disorders along with the recent development of PCR technologies and investments in the sector are some of the factors that have supported long-term expansion for PCR/RT Market.
The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. But the market of PCR/RT technology witnessed a boom during the pandemic as PCR is a standers test for gene sequencing and became an ideal tool for the lab testing for COVID-19
Asia Pacific is expected to be the largest market during the forecast period. The advancement in the healthcare system along with the increased research and development in the sector have led to growth in the PCR technology in the region.
Insights are provided for each region and major countries within the regions
|
Report Feature |
Descriptions |
|---|---|
|
Market Revenue In 2021 |
USD 7.5 billion |
|
Growth Rate |
CAGR of 6.7% during the forecasting period, 2021-2028 |
|
Historical Data |
2018-2019 |
|
Forecast Years |
2021-2028 |
|
Base Year |
2020 |
|
Units Considered |
Revenue in USD million and CAGR from 2021 to 2028 |
|
Report Segmentation |
Technique, Product, Application, End User and geography |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Thermo Fisher Scientific, Inc., F. Hoffman-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Takara Bio, Inc., Agilent Technologies, Inc., bioMérieux S.A., Fluidigm Corporation, Danaher Corporation, Abbott Laboratories, Merck KGaA, Becton Dickinson and Company, Promega Corporation, Eppendorf AG, and Analytik Jena AG |
|
Available Customization |
In addition to the market data for PCR/RT Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
PCR/RT Market is segmented into Technique, Product, Application, End User and geography.
.png)
.png)
.png)
.png)
.png)
.png)